Nils Spidsøe
Président chez MarBiLeads AS
Profil
Nils Spidsøe is currently the Chairman of MarBiLeads AS, Director at Sintef TTO AS, and Director at Funzionano AS.
Previously, he was the Director of Biosergen AS from 2012 to 2014 and a Professor at the Norwegian University of Science & Technology.
Postes actifs de Nils Spidsøe
| Sociétés | Poste | Début |
|---|---|---|
Sintef TTO AS
 Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | Director of Investments | 01/12/2004 |
MarBiLeads AS
 MarBiLeads AS BiotechnologyHealth Technology MarBiLeads AS engages in the development of drug candidates for infections and cancer based on marine microorganisms. The company was founded on December 22, 2010 and is headquartered in Trondheim, Norway. | Président | - |
Funzionano AS
 Funzionano AS Chemicals: SpecialtyProcess Industries Funzionano AS produces and sells functional nanotechnology-based hybrid polymers. It is a generic technology platform that has been developed at SINTEF materials and chemistry. The company is headquartered in Trondheim, Norway. | Directeur/Membre du Conseil | - |
Anciens postes connus de Nils Spidsøe
| Sociétés | Poste | Fin |
|---|---|---|
| Norwegian University of Science & Technology | Corporate Officer/Principal | - |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
MarBiLeads AS
MarBiLeads AS BiotechnologyHealth Technology MarBiLeads AS engages in the development of drug candidates for infections and cancer based on marine microorganisms. The company was founded on December 22, 2010 and is headquartered in Trondheim, Norway. | Health Technology |
Funzionano AS
Funzionano AS Chemicals: SpecialtyProcess Industries Funzionano AS produces and sells functional nanotechnology-based hybrid polymers. It is a generic technology platform that has been developed at SINTEF materials and chemistry. The company is headquartered in Trondheim, Norway. | Process Industries |
Sintef TTO AS
Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | Finance |
